Trials / Completed
CompletedNCT00655525
Omega-3 Fatty Acid Administration in Dialysis Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of this study is to examine the role of fish oil supplementation in ameliorating the inflammatory state of uremia and the related muscle protein catabolism associated with this disease state. We hypothesize that if administered for a period of 3 months, fish oil will improve the chronic uremic inflammation. We further hypothesize that fish oil administration will improve the muscle protein breakdown associated with uremia and inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | fish oil | 2.9 g of fish oil (2:1 EPA:DHA) administered orally every day for 3 months |
| DIETARY_SUPPLEMENT | placebo | placebo administered orally every day for 3 months |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2008-04-10
- Last updated
- 2014-04-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00655525. Inclusion in this directory is not an endorsement.